The hallucinations and delusions associated with psychosis can be frightening and may sometimes result in aggressive or violent behaviour. Of course, this can be incredibly challenging for the patient, but it can also be a real test for mental health staff who have to try and minimise the harm that patients do to themselves and others. Haloperidol [read the full story…]
The research and campaigns relating to life outcomes for people with schizophrenia and psychosis are truly shocking. It seems unbelievable that people with schizophrenia face a lifespan 15-20 years shorter than the general population and that only 7% are able to hold down a job. Paul Jenkins from Rethink Mental Illness sums it up nicely: [read the full story…]
There is an increasing body of research that suggests that inflammation plays an important role in the development of schizophrenia. It is therefore logical to consider using anti-inflammatory drugs as a component within the overall treatment approach for people with schizophrenia. This new systematic review and meta-analysis carried out by researchers from the University Medical [read the full story…]
There is a great deal of interest in using information and communication technology (ICT) to support and treat people with mental health conditions. In the broadest sense, ICT includes not just computers, but also telephones, TV and radio; essentially any medium that can communicate information in a multimedia format. ICT interventions can be delivered at [read the full story…]
The Scottish Government have published their annual summary of prescribing statistics for mental health drugs. The report shows increases in the prescribing rates for all groups of drugs over the last 12 months. The prescribing costs of some groups of drugs have also risen (ADHD, dementia, depression) although other groups have seen a decline (insomnia [read the full story…]
Over the last few years, we have seen more and more children and young people being prescribed antipsychotic drugs. The theory behind this increase is that the newer antipsychotic drugs have fewer side effects than the older typical antipsychotics. However, some small and relatively short duration studies have shown that the newer drugs may also [read the full story…]
Early intervention services for psychosis are aimed at people aged 14-35 who are experiencing a first episode of psychosis or at risk of doing so. The teams that work in this area usually include psychiatrists, psychologists, community psychiatric nurses, social workers and support workers. The NICE schizophrenia guideline recommends that early intervention services are offered [read the full story…]
People with schizophrenia often find it hard to do many of the day-to-day things that everyone else takes for granted. Simple tasks like eating healthily and washing can be challenging and more complex needs like developing relationships with other people and finding and holding down a job can seem like mountains to climb. Researchers refer [read the full story…]
The WHO World Health Survey is a comprehensive international survey carried out across 70 countries, which uses face-to-face, telephone and online interviews to ask questions about the health of populations, public health risk factors, coverage and availability of health services and health care spending. The survey includes a number of questions relating to mental health [read the full story…]
The two month consultation period for the new NICE guideline on psychosis and schizophrenia in children and young people has now begun. You must be registered as a stakeholder to comment on the guideline and you have until 27th September 2012 to make your views known. The guideline is aimed at clinicians and service commissioners [read the full story…]
